Hepatitis B is a serious liver disease that affects approximately one third of the world’s population, spread widely throughout Asia and Africa. It is estimated that 350 million people are chronic (lifelong) carriers, of which approximately 25% will develop cirrhosis and liver cancer. The World Health Organization (WHO) recommends the use of highly sensitive and specific immunoassays against hepatitis B surface antigen (HBsAg) to screen blood bank supplies for infection and prevent transmission. The presence or absence of additional antibodies and antigens serve as additional indicators to distinguish between acute and chronic infections enabling medical treatment to be directed accordingly.

A lateral flow chromatographic immunoassay for the qualitative detection of hepatitis B surface antigen (HBsAg) in human serum or plasma at a level equal to or higher than 1 ng/mL.

  • Uses serum or plasma
  • Can be performed without the use of laboratory equipment
  • Result in 15 minutes
  • Individually sealed foil pouches containing:
    • One cassette device
    • One desiccant
  • Plastic droppers
  • Package insert (instruction for use)

Catalog #

R0040C

Product

HBsAg Rapid Test

Quantity

30/kit

Specimen

S, P

Other Products You Might Be Interested In…

Catalog #

R0028C
R0023C
E0710

Product

HBsAg/HCV Ab Rapid Test
HCV Ab Plus Rapid Test
HBsAg Elisa Kit

Quantity

30/kit
30/kit

Specimen

S, P & WB
S, P